Clinical trial Recruiting at 3 sites Observational Ages 28 Days and up

Understanding brain development in congenital hypothyroidism: comparing affected children, healthy controls, and mild thyroid conditions

Official title: Understanding the Subnormal Rescue ofNeurological Development in Congenital Hypothyroidism (Comprendere le Ragioni Dell'Incompleta Correzione Dei Difetti Dello Sviluppo Neurologico Nell'Ipotiroidismo Congenito)

Run by Istituto Giannina Gaslini · NCT07893522 · Data updated 2026-11-12

This study tests how brain development in children with congenital hypothyroidism compares to similar children without the condition and to kids with a mild thyroid finding.

Quick facts

Study typeObservational
Ages28 Days and up
SexAll
Enrollment178 (estimated)
SponsorIstituto Giannina Gaslini
Academic / other
Locations3 sites (Genova and 2 other locations)
StatusRecruiting
StartedJune 20, 2024
Main results expectedDecember 5, 2025
Study endsDecember 2026
Registry record updatedOctober 26, 2026
Trial IDNCT07893522 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adults with congenital hypothyroidism, their family members, and healthy controls without thyroid-related issues.

Probably not a fit

Participants with intercurrent conditions that severely affect development or those unwilling to provide informed consent may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study seeks to understand why some children with congenital hypothyroidism (CH) have poorer neurological and cognitive development despite early treatment. It compares 39 CH patients to 39 matched controls, and 50 children with mild neonatal hyperthyrotropinemia to 50 controls, to identify factors related to development. Researchers will review medical histories, growth data, and cognitive test results to look for patterns. The study is conducted at multiple pediatric centers in Italy and is led by the Istituto Giannina Gaslini, with collaborations across participating institutions. No interventions are being tested; the goal is to learn more about development outcomes in CH and related thyroid conditions.

Why it matters

Potential benefit: Understanding factors that influence cognitive development in CH could help tailor monitoring and support for affected children.

How similar studies have gone: Previous research has explored CH outcomes and neurodevelopment, but this study adds a direct comparative design with multiple control groups.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults and minors with congenital hypothyroidism (CH).
* Family members of patients with CH.
* Healthy controls without thyroid-related conditions or other conditions that could interfere with the study.

Exclusion Criteria:

* Refusal to provide informed consent to participate in the study.
* Intercurrent conditions or severe comorbidities that could interfere with study procedures.

Where it's running

  • IRCCS Istituto G. Gaslini
    Genova, Italy
    Recruiting
  • Istituto Auxologico Milano
    Milan, Italy
    Recruiting
  • UOS di Endocrinologia Pediatrica del Dipartimento Assistenziale ad Attivita' Integrata Materno nfantile dell'Azienda Ospedaliera Universitaria Federico II di Napoli
    Naples, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.